CGMP routine inspection for Sulfamethazine & Amlodipine Besylate was conducted on March 23 to 27, 2015. FDA two inspectors inspected each system including production, testing, storage, and training. There were some observations found without critical findings. This is the fifth times US-FDA cGMP inspection since 2003 in our manufactory site.
You are here: Home > News >